DDX3X and neoplasm: Patients who presented with poor differentiation, invasion of the surrounding tissues and organs, lymph node metastasis, and TNM stages III and IV diseases had higher levels of CD112 and DDX3 than those with a well-differentiated tumor, no invasion, no lymph node metastasis, and TNM stages I and II disease.